Summary
This prediction ended on 15.12.21 with a price of €14.12. Massive losses of -45.17% were the result for the BUY prediction by yester. yester has 50% into this predictioniBio is a listed biotechnology company with the ticker symbol iBio that focuses on developing novel plant-based biologics and vaccines to combat infectious diseases and other medical conditions. The company leverages its proprietary expression technology to rapidly produce high-quality proteins at a commercial scale, providing a cost-effective and scalable alternative to traditional manufacturing processes. iBio has strategic collaborations with leading pharmaceutical companies and is actively exploring partnerships to advance its product pipeline and expand its reach. The company is headquartered in Bryan, Texas, and is publicly traded on the NYSE American stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| iBio Inc. | - | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to yester what are the pros and cons of iBio Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons
Comments by yester for this prediction
In the thread iBio Inc. diskutieren
In the thread Trading iBio Inc.
Die von yester gewählte maximale Laufzeit wurde überschritten